Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer

Authors
Publication date
1 January 2010
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università degli Studi di Udine

    redirect
    oaioai:air.uniud.it:11390/866844
    Last time updated on 12/11/2016